CJMBIndustrials · Integrated Freight & Logistics

CJMB Stock Forecast: Callan JMB, Inc. Price Predictions for 2026-2027

Last close, 30 Oct 2026

$0.42

−3.62% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 36 of 100 as at 31 Oct 2026 — in the lower half.

Market cap

$2.9M

Ticker Nerd rank

36/ 100

Median analyst target

—

Analysts covering

—

Revenue$1.4M−17.4% y/y

Operating income−$1.3M

Net income−$1.2M

Free cash flow−$430K

Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown

Total return, dividends reinvested

−26.6%

−82.7%

YTD

−62.1%

−89.6%

From 52W high

−90.0%

From 52W low

0.0%

$0.42

$4.20

52-week range, adjusted closes · the dot is the last close

Ticker Nerd rank

CJMB stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Callan JMB, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 31 Oct 2026

36/ 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size

Accruals

Volatility

Momentum

Value

Issuance

Quality

Revisions

Growth

Size (98): Smaller than most of the companies we track.

Growth (19): Sales and profits are flat, shrinking, or growing more slowly than they were.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

CJMB stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on CJMB, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

CJMB appears in the Radar on the weeks it earns a place.

Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
The AI build-out map, free: every AI company we track, part by part, and one part in full with each verdict.

The AI build-out map

PDF

AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST

Performance

CJMB vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 30 Oct 2026, Callan JMB, Inc. returned −89.6% against +12.4% for the S&P 500, dividends included.

CJMB vs S&P 500, last 12 monthsTotal return, rebased to 100

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

CJMB analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Callan JMB, Inc. (CJMB) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: −0.2×
Price / sales: 0.6×
Price / book: 3.5×
EV / EBITDA: −0.5×

Growth & margins

Revenue growth (YoY): −17.4%
Earnings growth (YoY): −17.4%
Gross margin: 55.1%
Operating margin: −97.8%
Net margin: −192.0%

Returns & dividend

Return on equity: −300.3%
Return on assets: −64.2%
Dividend yield: 0.0%

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Callan JMB, Inc. (CJMB) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

Callan JMB, Inc. has a market value of $2.9M and an enterprise value of $3.7M.
Revenue in the twelve months to 30 June 2026: $5.1M. The latest quarter shrank 17.4% year on year.
Net income over the same four quarters: −$9.8M, a −192.0% net margin.
Free cash flow in the twelve months to 30 June 2026: −$4.7M.
Shares outstanding: 5.7M.
Trailing P/E: −0.2×.
Forward dividend yield: 0.00%, paying out 0% of earnings.
Callan JMB, Inc. employs 18 people — $283K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 31 Oct 2026

Data provided by Twelve Data

Peers

CJMB vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelIntegrated Freight & Logistics

Company	Market cap	TKN rank
CJMBCallan JMB, Inc.	$2.9M	36
HXHXHaoxin Holdings Ltd.	$2.5M	15
SGLYSingularity Future Technology Ltd.	$2.8M	9
CTNTCheetah Net Supply Chain Service, Inc.	$2.8M	24
CIITTianci International, Inc.	$1.6M	19
GVHGlobavend Holdings Ltd.	$4.0M	21
BTOCArmlogi Holding Corp.	$6.3M	51

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Callan JMB, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest CJMB news & analysis

Callan JMB to Break Ground on IV Bag Manufacturing Facility Fully Funded by Non-Dilutive and Non-Interest-Bearing Third-Party Partnership

GlobeNewsWire · 22 Oct 2026positive

Callan JMB said it plans to break ground on an IV bag manufacturing and distribution facility at its Atlas Complex in Marion, Alabama. The $16 million project will be funded by a third party through a non-dilutive, non-interest-bearing partnership.

Why it matters — The project advances the company’s pharmaceutical manufacturing strategy and adds planned IV bag production capacity to its operations.

Callan JMB Advances IV Bag Manufacturing Facility with Projected $450 Million in Annual Revenue

GlobeNewsWire · 20 Oct 2026positive

Callan JMB announced formal approval of blueprints for a planned $16 million IV bag manufacturing and distribution facility at the Atlas Complex in Marion, Alabama. Once in production, the facility is projected to generate $450 million in annual revenue: $300 million from standard IV bags and $150 million from premixed drug IV bags.

Why it matters — The project advances CJMB’s pharmaceutical manufacturing strategy and is intended to strengthen its role in U.S. healthcare supply-chain preparedness.

Callan JMB Advances U.S. Pharmaceutical Manufacturing at the Atlas Complex and Expands into North American Equipment Distribution and Assembly

GlobeNewsWire · 8 Oct 2026positive

Callan JMB said it plans to invest approximately $28 million in TRUKING equipment for the Atlas Complex, advancing U.S. pharmaceutical manufacturing capacity and expanding into North American equipment distribution and assembly.

Why it matters — The planned equipment investment is intended to strengthen the company's preparedness strategy and support new commercial opportunities.

FAQ

Frequently asked questions about CJMB stock

How does Ticker Nerd's model rank CJMB?

As at 31 Oct 2026, Callan JMB, Inc. ranks 36 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (98 of 100).

What is the CJMB stock forecast for 2030?

No analyst covering Callan JMB, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CJMB are extrapolating price history, which says nothing about the business.

How has CJMB stock performed over the past year?

Callan JMB, Inc. returned -89.6% over the 12 months to 30 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Callan JMB, Inc. do?

Callan JMB Inc. is a specialty logistics and fulfillment company focused on temperature-controlled handling for the life sciences sector.

What is the latest news on CJMB?

The most recent item we track (GlobeNewsWire, 22 Oct 2026): "Callan JMB to Break Ground on IV Bag Manufacturing Facility Fully Funded by Non-Dilutive and Non-Interest-Bearing Third-Party Partnership". Callan JMB said it plans to break ground on an IV bag manufacturing and distribution facility at its Atlas Complex in Marion, Alabama. The $16 million project will be funded by a third party through a non-dilutive, non-interest-bearing partnership.

Company

About Callan JMB, Inc.

Callan JMB Inc. is a specialty logistics and fulfillment company focused on temperature-controlled handling for the life sciences sector. The company provides cold chain solutions that support the transport, storage, monitoring, and protection of highly sensitive medical and biological materials, including vaccines, diagnostics, cell therapies, stem cells, biopharmaceuticals, and other regulated products. Its services combine proprietary packaging, information technology, and specialized cold chain know-how to help maintain product integrity across time-sensitive supply chains. Callan JMB also serves emergency preparedness and response needs through product fulfillment, medical stockpiles, and rapid deployment support for critical materials. Based in Spring Branch, Texas, the company operates through its principal subsidiary and works with healthcare, pharmaceutical, and emergency management customers that require compliant, reliable logistics for essential products.

CEO Mr. Wayne Williams · 18 employees · United States · https://callanjmb.com